Literature DB >> 22872018

Maternal diclofenac medication in pregnancy causing in utero closure of the fetal ductus arteriosus and hydrops.

Aravind T Shastri1, Dalia Abdulkarim, Paul Clarke.   

Abstract

This report describes a case of premature closure in utero of the ductus arteriosus (DA) diagnosed postnatally in a baby with hydrops and cardiac failure. An echocardiogram 6 h postnatally showed marked dilation of the right atrium and right ventricle with marked hypertrophy and impaired function, elevated pulmonary pressures, a small pericardial effusion, and no flow through the DA. The mother was unaware of her pregnancy until she presented in labor, and she had taken diclofenac medication in the preceding months. This case and the accompanying literature review illustrate the potential fetal and neonatal complications resulting from antenatal closure of the DA due to maternal diclofenac medication during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872018     DOI: 10.1007/s00246-012-0461-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  Premature in utero closure of the ductus arteriosus following maternal ingestion of sodium diclofenac.

Authors:  C Mas; S Menahem
Journal:  Aust N Z J Obstet Gynaecol       Date:  1999-02       Impact factor: 2.100

Review 2.  Prenatal diagnosis of intrauterine premature closure of the ductus arteriosus following maternal diclofenac application.

Authors:  M Auer; C Brezinka; P Eller; K Luze; U Schweigmann; P Schwärzler
Journal:  Ultrasound Obstet Gynecol       Date:  2004-05       Impact factor: 7.299

3.  The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age.

Authors:  S T Vermillion; J A Scardo; A G Lashus; H B Wiles
Journal:  Am J Obstet Gynecol       Date:  1997-08       Impact factor: 8.661

4.  Fetal and neonatal effects of indomethacin used as a tocolytic agent.

Authors:  D K Dudley; M J Hardie
Journal:  Am J Obstet Gynecol       Date:  1985-01-15       Impact factor: 8.661

5.  Clinical features of the complete closure of the ductus arteriosus prenatally.

Authors:  Hidekazu Ishida; Noboru Inamura; Yukiko Kawazu; Futoshi Kayatani
Journal:  Congenit Heart Dis       Date:  2011 Jan-Feb       Impact factor: 2.007

6.  Contraction of the fetal ductus arteriosus induced by diclofenac. Case report.

Authors:  A J Rein; M Nadjari; U Elchalal; A Nir
Journal:  Fetal Diagn Ther       Date:  1999 Jan-Feb       Impact factor: 2.587

7.  Administration of prostaglandin inhibitors to the mother; the potential risk to the fetus and neonate with duct-dependent circulation.

Authors:  S Menahem
Journal:  Reprod Fertil Dev       Date:  1991       Impact factor: 2.311

8.  Premature foetal closure of the arterial duct: clinical presentations and outcome.

Authors:  Marc Gewillig; Stephen C Brown; Luc De Catte; Anne Debeer; Benedicte Eyskens; Veerle Cossey; Dominique Van Schoubroeck; Chris Van Hole; Roland Devlieger
Journal:  Eur Heart J       Date:  2009-04-23       Impact factor: 29.983

9.  The incidence and outcome of concealed pregnancies among hospital deliveries: an 11-year population-based study in South Glamorgan.

Authors:  D Nirmal; I Thijs; J Bethel; P S Bhal
Journal:  J Obstet Gynaecol       Date:  2006-02       Impact factor: 1.246

10.  Role of the pulmonary circulation in the distribution of human fetal cardiac output during the second half of pregnancy.

Authors:  J Rasanen; D C Wood; S Weiner; A Ludomirski; J C Huhta
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

View more
  2 in total

1.  Prenatal constriction of the ductus arteriosus following maternal diclofenac medication in the third trimester.

Authors:  Karoline Aker; Anne Brantberg; Siri Ann Nyrnes
Journal:  BMJ Case Rep       Date:  2015-10-01

Review 2.  [Maternal use of non-steroidal antiinflammatory drugs and closure of the ductus arteriosus].

Authors:  Daouda Diamane Ndour
Journal:  Pan Afr Med J       Date:  2016-12-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.